A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Rondo Therapeutics
Rondo Therapeutics
Biogenea Pharmaceuticals Ltd.
A2 Biotherapeutics Inc.
Guided Therapeutics
Shandong New Time Pharmaceutical Co., LTD
VitaMed Research LLC